The Market Reports

Synopsis
The global market for Man-made Vascular Graft was estimated to be worth US$ 4034 million in 2024 and is forecast to a readjusted size of US$ 5876 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Man-made Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.
Expanding Market Size
With continuous advancements in medical technology and intensifying population aging, the market size for artificial blood vessels in China is also expanding steadily. It is estimated that the growth rate of the Chinese market will exceed the global average in the coming years.
Technological Innovation Driving Market Development
Application of New Materials: The field of artificial blood vessels is moving towards the direction of biodegradability, enhanced biocompatibility, and superior biomechanical properties. The application of biodegradable materials such as polylactic acid (PLA) and polycaprolactone (PCL) is expected to reduce the risks associated with long-term implantation in the body and improve patients' quality of life. The integration of nanotechnology has also brought new opportunities for enhancing the performance of artificial blood vessels. The application of nano-coatings and nano-fibers can enhance the blood vessels' antithrombotic capabilities, antibacterial properties, and durability, making artificial blood vessels safer and more reliable in clinical applications.
Advancements in Bioprinting Technology: Bioprinting allows for the manufacturing of artificial blood vessels with complex structures and functions, better matching the physiological characteristics of human blood vessels, thus improving surgical success rates and patients' recovery speeds. Additionally, bioprinting technology enables the customization of artificial blood vessels to meet the diverse needs of different patients and surgical procedures.
Intensifying Competition and Rising Market Concentration
Competition Among Domestic and Foreign Enterprises: With the entrance of both domestic and foreign enterprises, competition in the artificial blood vessel market is becoming increasingly fierce. Companies need to continuously reduce costs to maintain their competitiveness while increasing investments in innovation and research and development to create differentiated advantages.
Rising Market Concentration: The concentration of the Chinese artificial blood vessel market is relatively high, with major market participants occupying a significant market share. This concentration is reflected in diverse product lines, strong brand influence, and extensive market coverage. In the future, with intensifying market competition and industry consolidation, market concentration is expected to further increase.
Policies and Health Insurance Support Promoting Market Development
Policy Support: Government departments such as the National Development and Reform Commission have increased investments in medical services, promoting healthy capital flows for enterprises through policy support and accelerating industry development.
Health Insurance Coverage: The improvement of the health insurance system has made artificial blood vessel treatments more affordable for more patients, further driving the growth of market demand. In the future, with the expansion of health insurance coverage and optimization of reimbursement policies, the demand for artificial blood vessels is expected to further increase.
This report aims to provide a comprehensive presentation of the global market for Man-made Vascular Graft, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Man-made Vascular Graft by region & country, by Type, and by Application.
The Man-made Vascular Graft market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Man-made Vascular Graft.
Market Segmentation
By Company
Getinge
Bard PV
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Shanghai Chest Medical Instruments
Aortec Medical Technology
JIANGSU BIODA LIFE SCIENCE
Segment by Type
ePTFE Man-made Vascular Graft
Polyester Man-made Vascular Graft
PTFE Man-made Vascular Graft
Others
Segment by Application
Aortic Disease
Peripheral Artery Disease
Hemodialysis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Man-made Vascular Graft manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Man-made Vascular Graft in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Man-made Vascular Graft in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index